Raymond James & Associates’s Adtran ADTN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-31,815
| Closed | -$173K | – | 3953 |
|
|
2024
Q1 | $173K | Buy |
31,815
+3,485
| +12% | +$22.2K | ﹤0.01% | 3651 |
|
|
2023
Q4 | $208K | Sell |
28,330
-882
| -3% | -$5.81K | ﹤0.01% | 3511 |
|
|
2023
Q3 | $240K | Buy |
29,212
+18
| +0.1% | +$160 | ﹤0.01% | 3359 |
|
|
2023
Q2 | $307K | Sell |
29,194
-79
| -0.3% | -$784 | ﹤0.01% | 3241 |
|
|
2023
Q1 | $464K | Buy |
29,273
+105
| +0.4% | +$1.82K | ﹤0.01% | 2964 |
|
|
2022
Q4 | $548K | Buy |
29,168
+7,903
| +37% | +$159K | ﹤0.01% | 2840 |
|
|
2022
Q3 | $416K | Buy |
21,265
+499
| +2% | +$10.9K | ﹤0.01% | 2973 |
|
|
2022
Q2 | $364K | Buy |
20,766
+827
| +4% | +$15K | ﹤0.01% | 3106 |
|
|
2022
Q1 | $368K | Buy |
19,939
+995
| +5% | +$19.7K | ﹤0.01% | 3270 |
|
|
2021
Q4 | $432K | Buy |
18,944
+1,849
| +11% | +$37.4K | ﹤0.01% | 3196 |
|
|
2021
Q3 | $321K | Buy |
17,095
+692
| +4% | +$14.6K | ﹤0.01% | 3360 |
|
|
2021
Q2 | $339K | Buy |
16,403
+3,006
| +22% | +$58.1K | ﹤0.01% | 3345 |
|
|
2021
Q1 | $223K | Buy |
+13,397
| New | +$226K | ﹤0.01% | 3543 |
|
|
2020
Q4 | – | Sell |
-10,882
| Closed | -$112K | – | 3757 |
|
|
2020
Q3 | $112K | Sell |
10,882
-2,625
| -19% | -$29.7K | ﹤0.01% | 3363 |
|
|
2020
Q2 | $148K | Buy |
13,507
+1,642
| +14% | +$17K | ﹤0.01% | 3207 |
|
|
2020
Q1 | $91K | Sell |
11,865
-1,030
| -8% | -$8.8K | ﹤0.01% | 3234 |
|
|
2019
Q4 | $128K | Sell |
12,895
-3,233
| -20% | -$30.8K | ﹤0.01% | 3441 |
|
|
2019
Q3 | $183K | Buy |
16,128
+820
| +5% | +$9.74K | ﹤0.01% | 3291 |
|
|
2019
Q2 | $233K | Sell |
15,308
-399
| -3% | -$6.37K | ﹤0.01% | 3153 |
|
|
2019
Q1 | $215K | Buy |
15,707
+421
| +3% | +$5.82K | ﹤0.01% | 3198 |
|
|
2018
Q4 | $164K | Sell |
15,286
-1,036
| -6% | -$14.1K | ﹤0.01% | 3206 |
|
|
2018
Q3 | $288K | Sell |
16,322
-1,967
| -11% | -$32.8K | ﹤0.01% | 3057 |
|
|
2018
Q2 | $272K | Buy |
+18,289
| New | +$273K | ﹤0.01% | 3084 |
|
|
2015
Q1 | – | Sell |
-30,693
| Closed | -$669K | – | 2328 |
|
|
2014
Q4 | $669K | Sell |
30,693
-5,962
| -16% | -$122K | ﹤0.01% | 1803 |
|
|
2014
Q3 | $753K | Buy |
36,655
+6,062
| +20% | +$136K | ﹤0.01% | 1661 |
|
|
2014
Q2 | $690K | Sell |
30,593
-9,510
| -24% | -$215K | ﹤0.01% | 1701 |
|
|
2014
Q1 | $979K | Buy |
40,103
+30,000
| +297% | +$773K | 0.01% | 1433 |
|
|
2013
Q4 | $273K | Buy |
+10,103
| New | +$254K | ﹤0.01% | 1877 |
|
|
2013
Q3 | – | Sell |
-41,503
| Closed | -$1.02M | – | 1903 |
|
|
2013
Q2 | $1.02M | Buy |
+41,503
| New | +$919K | 0.01% | 1159 |
|
Other funds holding ADTN
DCM
PCMI
Raymond James & Associates's ADTN Position: Q2 2024 in Review
Raymond James & Associates sold out of Adtran (ADTN) in Q2 2024, closing a stake of 31,815 shares — an estimated $173K sold.
Raymond James & Associates first reported a position in ADTN in Q2 2013 and held it in 29 quarters. The position peaked at $1.02M in Q2 2013. 157 funds tracked by Wall St. Rank hold ADTN as of Q2 2024.
- Raymond James & Associates reported no remaining Adtran position as of Q2 2024 after selling out during the quarter.
- Raymond James & Associates sold 31,815 Adtran shares in Q2 2024, an estimated $173K.
- Raymond James & Associates first reported a position in Adtran in Q2 2013 and held it in 29 quarters.
- Raymond James & Associates's Adtran position peaked at $1.02M in Q2 2013.
- 157 funds tracked by Wall St. Rank held Adtran as of Q2 2024.
Based on Raymond James & Associates's 13F filing for Q2 2024, filed 19 Jul 2024.